RESEARCH FUNDING Active grants for which I am the principal investigator Total Amount Duration Grant Agency Project Title awarded (CAD) 33,000 01/2015 Astellas Pharma Inc. Molecular Pathology Applications in – 06/2016 Canada Transplantation 750,000 04/2014 Alberta Innovates and The Alberta Laboratory for Molecular – 10/2016 Advanced Education Diagnostics: A Provincial Facility of – Concept Study 20,000 10/2013 Bertech Pharma Validation of a immunohistochemical stain – 12/2015 for cancer screening on peripheral blood smears 463,000 12/2012 Leaders Opportunity Translational Pathology Unit – 03/2016 Fund, Canadian Foundation of Innovation (186,000$) + matching funds by AET and in kind Current active, funded Research for which I am a co-investigator Total Amount Duration Agency Project Title awarded (CAD) 35,000 01/2015 University Hospital Molecular diagnostics of antibody-mediated – 12/2015 Foundation kidney transplant rejection: Diagnostic and Prognostic Biomarker test development for clinical use 45,000 05/2014 Division of Nephrology, Molecular diagnostics of antibody-mediated – 12/2015 University of Alberta injury in formalin-fixed, paraffin embedded human kidney biopsies 120,000 11/2012 Roche Organ Creation of Swiss Foundation Legal Entity for – 04/2016 Transplant Research the Banff Allograft Pathology Classification Foundation and Consensus Process (PI Kim Solez) – 5,000,000.00 06/2013 Alberta Innovates Metabolomic Devices for Companion – 05/2018 Health Solutions Diagnostics and Personalized Medicine (PI – David Wishart) 4,500,000.00 04/2013 Genome Canada PACE - 'Omics: Personalized, Accessible, – 03/2017 Cost-Effective applications of 'Omics technologies (PIs Christopher McCabe and – Tania Bubela) Past Research Funding
RESEARCH FUNDING Active grants for which I am the principal investigator Total Amount awarded (CAD) Duration Grant Agency Project Title 33,000 01/2015 – 06/2016 Astellas Pharma Inc. Canada Molecular Pathology Applications in Transplantation 750,000 04/2014 – 10/2016 Alberta Innovates and Advanced Education The Alberta Laboratory for Molecular Diagnostics: A Provincial Facility – of Concept Study 20,000 10/2013 – 12/2015 Bertech Pharma Validation of a immunohistochemical stain for cancer screening on peripheral blood smears 463,000 12/2012 – 03/2016 Leaders Opportunity Fund, Canadian Foundation of Innovation (186,000$) + matching funds by AET and in kind Translational Pathology Unit Current active, funded Research for which I am a co-investigator Total Amount awarded (CAD) Duration Agency Project Title 35,000 01/2015 – 12/2015 University Hospital Foundation Molecular diagnostics of antibody-mediated kidney transplant rejection: Diagnostic and Prognostic Biomarker test development for clinical use 45,000 05/2014 – 12/2015 Division of Nephrology, University of Alberta Molecular diagnostics of antibody-mediated injury in formalin-fixed, paraffin embedded human kidney biopsies 120,000 11/2012 – 04/2016 Roche Organ Transplant Research Foundation Creation of Swiss Foundation Legal Entity for the Banff Allograft Pathology Classification and Consensus Process (PI – Kim Solez) 5,000,000.00 06/2013 – 05/2018 Alberta Innovates Health Solutions Metabolomic Devices for Companion Diagnostics and Personalized Medicine (PI – David Wishart) 4,500,000.00 04/2013 – 03/2017 Genome Canada PACE - 'Omics: Personalized, Accessible, Cost-Effective applications of 'Omics technologies (PIs – Christopher McCabe and Tania Bubela) Past Research Funding